APA (7th ed.) Citation

Miteva, D., Kitanova, M., Batselova, H., Lazova, S., Chervenkov, L., Peshevska-Sekulovska, M., . . . Velikova, T. (2023). The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice. Vaccines, 11(7), 1181. https://doi.org/10.3390/vaccines11071181

Chicago Style (17th ed.) Citation

Miteva, Dimitrina, et al. "The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice." Vaccines 11, no. 7 (2023): 1181. https://doi.org/10.3390/vaccines11071181.

MLA (9th ed.) Citation

Miteva, Dimitrina, et al. "The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice." Vaccines, vol. 11, no. 7, 2023, p. 1181, https://doi.org/10.3390/vaccines11071181.